Table 1.
|
|
All patients (N= 406) |
p16 status available (N = 199) |
|||
---|---|---|---|---|---|---|
p16 + (N=118) | p16 - (N=81) | p-value | ||||
Average age |
|
59.1 |
±10.9 |
55.9 |
60.7 |
0.003* |
Sex |
Male |
327 |
79.8% |
86.6% |
76.3% |
0.047* |
|
Female |
83 |
20.2% |
|
|
|
Smokers |
|
281 |
68.5% |
63.5% |
86.8% |
0.0008* |
Stage |
IV |
308 |
78.8% |
75.6% |
80.0% |
0.49 |
|
III |
58 |
14.2% |
18.5% |
11.3% |
0.23 |
|
II |
26 |
6.3% |
2.5% |
3.7% |
0.68 |
|
I |
14 |
3.4% |
1.7% |
2.5% |
0.99 |
Index tumour location |
Tonsils |
213 |
68.7% |
|
|
|
|
Base of the tongue |
90 |
29.0% |
|
|
|
|
Oropharynx NOS |
15 |
4.8% |
|
|
|
|
Soft palate |
18 |
5.8% |
|
|
|
|
Pharyngeal walls |
15 |
4.8% |
|
|
|
Treatment |
Surgery+ChemoRT |
143 |
34.9% |
|
|
|
|
ChemoRT |
216 |
52.7% |
|
|
|
|
Palliative |
16 |
3.9% |
|
|
|
|
Salvage surgery |
11 |
2.7% |
|
|
|
|
No treatment |
21 |
5.1% |
|
|
|
Follow-up (years) | 3.9 | ± 1.0 | 3.9 | 3.9 | 0.98 |
p < 0.05 considered statistically significant. NOS = not otherwise specified.